From Europe to Brazil: Bridging the CE Mark and ANVISA Gap

This episode demystifies the process of bringing a CE-marked medical device to the Brazilian market. We break down the critical differences between European requirements and Brazil's ANVISA regulations, focusing on the essential documentation, testing, and certification gaps that manufacturers must address for successful registration. • Is a CE mark enough to sell your medical device in Brazil? • What is a Brazil Registration Holder (BRH) and why is it mandatory? • How does ANVISA's technical dossier differ from a European Technical File? • Can an MDSAP certificate replace the need for an ANVISA factory inspection? • What is INMETRO certification and does my electrical device require it? • Are my existing ISO 10993 biocompatibility test reports valid for Brazil? • How has the new RDC 751/2022 regulation changed the registration process? • What are the strict translation requirements for ANVISA submissions? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.